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Abstract Gaining a full understanding of the mechanisms of action of natural products as therapeutic agents includes
observing the effects of natural products on cellular morphology, because abnormal cellular morphology is an important
aspect of cellular transformations that occur as part of disease states. In this study a set of natural products was examined in
search of small molecules that influence the cylindrical morphology of fission yeast Schizosaccharomyces pombe. Imaging
flow cytometry of large populations of S. pombe exposed to natural products captured cell images and revealed changes in
mean length and aspect ratio of cells. Several natural products were found to alter S. pombe’s morphology relative to
control, in terms of elongating cells, shrinking them, or making them more round. These results may facilitate future
investigations into methods by which cells establish and maintain specific shapes.
Keywords Schizosaccharomyces pombe  Morphology  Natural products  Imaging flow cytometry  Aspect
ratio  Fission yeast
1 Introduction
Cell morphology is frequently altered in cancer cells,
which are phenotypically categorized based largely upon
morphological characteristics. It is generally assumed that
genomic mutations in components of signaling networks
directly or indirectly result in morphological alterations
that allow growth advantages [1]. For example, mutations
that allow cells to sample a wider variety of morphological
space may permit delamination and metastasis. In support
of this view, a genome wide screen in search of genes that
regulate cell shape transitions in Drosophila hematocytes
led to the identification of mutations in a subset of sig-
naling genes, including the tumor suppressor PTEN, that
produce nonheterogeneous populations of cells that switch
between rounded and elongated morphologies [2].
Switching back and forth between these shapes may allow
cells to sample a large amount of cellular space in search of
a shape that permits metastasis. For example, a rounded
shape may facilitate passage through the bloodstream while
an elongated shape may facilitate migration through harder
tissues like bone. The intermediate shapes that arise when
these mutant cells switch from round to elongated and vice
versa may permit other events of metastasis, such as
delamination from an epithelial layer [2].
High-throughput screens have led to the identification of
small molecules that specifically alter mammalian mor-
phology and facilitate biomedical discoveries [3, 4].
However, major challenges in isolating morphological
effects face those attempting to isolate these chemicals in a
high-throughput manner using mammalian cells. For
example, such assays require a large population of dividing
cells. These populations are typically assembled using
cancerous cell lines that already have altered morphology
together with genomic mutations capable of masking
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effects of small molecules. The rampant crosstalk that
occurs among mammalian signaling pathways can also
mask the effect of small molecules. Furthermore, mam-
malian cells are wired with many signaling pathways, such
as developmental and survival pathways, that influence
morphology in a variety of ways. Therefore, small mole-
cules found to alter mammalian morphology may do so
indirectly by modulating one of these pathways. In this
case it becomes difficult to separate physiological changes
that result from morphological alterations as opposed to
abnormal cell signaling.
Schizosaccharomyces pombe is a model system for
investigating pathways that eukaryotic cells use to sample
morphological space [5]. Yeast like S. pombe also appear
to have a reduced level of signaling crosstalk, given that a
full yeast protein–protein interaction network contains
roughly 37,800–75,500 interactions while the human net-
work is made up of *154,000–369,000 interactions [6].
Previously, we demonstrated that image flow cytometry
(IFC) can be used to accurately capture and quantify the
morphological changes that accompany specific S. pombe
mutations [7]. For example, IFC was used to accurately
khellin artemisinine bactobolin
tetrocarcin A lonchocarpic acid michellamine B
parthenolide beta lapachone castanospermine
triptolide analog glaucarubine Curcumin
Fig. 1 Natural products from NCI Open Chemical Repository Collection Natural Products Set II
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describe the more spherical appearance of cells that lack
rad24?, a nonessential gene that encodes a 14-3-3 protein
[8]. Whereas wildtype cells are cylindrical and have aspect
ratios (AR, calculated as width/length) of 0.47, rad24
mutants are more spherical and found to have elevated ARs
(0.58). IFC was also able to accurately capture and quantify
the predicted changes in cell length and AR known to
accompany treatment following a variety of DNA damag-
ing agents and cytoskeletal toxins. Therefore, IFC is a
powerful tool that can be used to accurately describe
morphological changes that occur in S. pombe as a result of
genetic and chemical manipulations.
Given the power of IFC to sensitively quantify mor-
phological changes resulting from chemical exposure, the
United States National Cancer Institute Natural Products
Set II was an interesting set of compounds to explore. The
set contains many natural products with known medicinal
or therapeutic effects. In this work, we selected twelve
compounds in the NCI natural products library with well-
known medicinal or therapeutic uses for molecules, and we
Fig. 2 Images collected with FlowCAM IFC. Panels contain most
elongated images from each representative sample, for comparison.
A S. pombe cells subjected to khellin (NSC#8519) exhibiting with
lengths ranging from 10.29 to 11.51 lm represented. B S. pombe cells
subjected to no NP (control) with lengths from 9.09 to 9.88 lm
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observed their ability to alter length or AR of S. pombe.
Those twelve compounds appear in Fig. 1.
It is important to note that we are reporting on the
morphological changes that occur following exposure to
these natural products, not cell population growth as has
been reported on previously [9]. Therefore, ours is the first
report to address the effects of these compounds on yeast
cell shape.
2 Results and Discussion
Figure 2 shows two representative examples of image data
collected in this study. Cells exposed to khellin are shown
in Panel A, and untreated control cells are shown in Panel
B. Both panels display the most elongated cells in the data
set. The khellin-exposed cells shown range from 10.29 to
11.51 um in length, whereas the control cells shown range
from 9.09 to 9.88 lm. This comparison indicates that the
longest khellin-exposed cells are longer than the longest
control cells. Although this is a comparison of the longest
cells in both sets, this analysis is reflected in the fact that
the mean length of khellin-exposed cells is 114.7 % of the
mean length of control cells.
Table 1 shows cell length and aspect ratio ratioed to
control after treatment with each natural product (NP), for
each of three trials for each natural product. Standard
deviations were calculated from the standard deviations of
the NP-exposed value and control value, using a partial
derivative formula [10]. An L/Lc less than 100 % indicates
that the cells are shorter than the control, and an L/Lc
greater than 100 % indicates that cells are longer than the
control. Aspect ratio (AR), which is calculated as width
divided by length, becomes smaller as cells become more
elongated. So an AR/ARc less than 100 % indicates that
cells are narrower and more elongated than the control.
AR/ARc greater than 100 % indicates that cells are more
rounded than the control. As a comparison, and in order to
estimate the strength of observed effects, Table 1 also













Trial 1 121.7 94.1 114.7 ± 9.2 97.5 ± 8.0
Trial 2 112.6 101.6
Trial 3 109.7 96.6
Artemisinine
Trial 1 101.0 106.8 103.9 ± 3.6 106.0 ± 2.1
Trial 2 106.0 106.5
Trial 3 104.8 104.7
Beta-lapachone
Trial 1 103.7 98.6 102.9 ± 5.3 98.9 ± 3.9
Trial 2 100.4 99.3
Trial 3 104.7 98.9
Lonchocarpic acid
Trial 1 102.7 109.5 101.4 ± 2.8 111.5 ± 2.7
Trial 2 101.5 112.0
Trial 3 99.9 113.0
Castanospermine
Trial 1 99.9 100.3 101.0 ± 4.8 98.9 ± 4.5
Trial 2 100.9 100.3
Trial 3 102.0 96.3
Curcumin
Trial 1 101.4 103.9 100.5 ± 5.0 101.6 ± 4.5
Trial 2 101.9 99.8
Trial 3 98.2 101.0
Glaucarubine
Trial 1 92.6 102.5 98.1 ± 6.6 100.9 ± 4.3
Trial 2 101.2 101.2
Trial 3 100.5 99.2
Triptolide
Trial 1 97.3 101.5 98.0 ± 5.8 99.3 ± 7.5
Trial 2 98.5 96.9
Trial 3 98.1 99.6
Parthenolide
Trial 1 103.4 89.6 98.0 ± 4.9 91.4 ± 2.8
Trial 2 94.6 91.8
Trial 3 95.9 92.7
Michellamine B
Trial 1 94.5 90.3 97.0 ± 2.5 92.9 ± 3.4
Trial 2 98.0 95.1
Trial 3 98.5 93.3
Tetrocarcin A
Trial 1 96.2 99.7 96.7 ± 1.6 99.4 ± 2.7
Trial 2 95.9 100.2
Trial 3 98.0 98.2
Bactobolin












Trial 2 95.8 97.2
Trial 3 85.0 96.4
Phleomycin [7] 157.9 ± 17.5 64.6 ± 13.1
a L/Lc = mean length of NP-exposed cells divided by mean length
of control cells (not exposed to NP), as a percentage. Both NP-
exposed and control measurements were performed in triplicate
b AR/ARc = mean aspect ratio of NP-exposed cells divided by mean
length of control cells (not exposed to NP), as a percentage
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shows cell length and aspect ratio for an established fun-
gicidal drug, phleomycin, which exhibits L/Lc of 157.9 %
and AR/ARC of 64.6 %.
Khellin and artemisinine produced the longest S. pombe
cells, resulting in 114.7 and 103.9 % respective increases
in mean length over that of the control cells. Bactobolin
and tetrocarcin A produced the shortest cells, 92.2 and
96.7 % respectively, when compared to untreated controls.
Lonchocarpic acid and artemisinine increased the AR of
cells considerably, yielding 111.5 and 106.0 % of control
respectively. Michellamine B and parthenolide treatments
significantly reduced the AR of cells, to 92.9, and 91.4 %,
respectively. Five NPs showed no measurable effect: beta-
lapachone, castanospermine, curcumin, glaucarubine, and
triptolide analog.
Each NP is discussed below, in terms of its chemical and
species family, any known medicinal properties, other
pertinent information about its mechanism of action that
yield those properties, and its effects on S. pombe cell
shape observed in this study. Connections are made
between a NP’s effects on S. pombe and these other
properties wherever possible.
2.1 Khellin
Khellin is a member of the furanochromone family. It is
commercially available but was originally used and then
isolated from the flowering plant Ammi visnaga, native to
the Middle East [11]. Khellin is a vasodilator and bron-
chodilator [12]. It has been implicated, along with its
chemical relative visnagin, in the inhibition of nuclear
factor jB [13]. It is an anti-inflammatory agent, and its
mechanism of action is blocking the calcium channel in
cells [11]. In S. pombe, khellin has the effect of lengthening
cells: L/Lc is considerably larger than 100 %. But AR is
relatively unchanged, so width is commensurately
increasing along with length. This demonstrates that
khellin has enlarged the cell. It may be doing so by
affecting the S. pombe calcium channel and leading to
altered intracellular calcium concentrations are important
for cell wall integrity, cytokinesis, and cytoskeletal orga-
nization [14]. The mechanical strength of the cell wall may
also be affected by intracellular calcium. These effects may
weaken the overall cell wall and causing the cell to enlarge,
possibly by allowing in higher volumes of water or media
into the intracellular space. Another possibility is that
Khellin may damage DNA and activate cell cycle check-
points that lead to the production elongated cells. Or
khellin may work by an entirely different mechanism that
has yet to be identified.
2.2 Artemisinine
Artemisinine is a sesquiterpene lactone that contains an
endoperoxide bridge. It originates from the wormwood
plant Artemisia annua, is used in traditional Chinese
medicine, and is a well-known antimalarial agent. The
endoperoxide bridge is essential for its antimalarial activity
[15], because it breaks up to form carbon-centered radicals
that are destructive to the malaria parasite Plasmodium
falciparum. This free radical formation requires iron or
heme to occur.
In this study, artemisinine produces an AR/ARc greater
than 100 % in S. pombe, meaning that the cells are rounder
than control. This indicates some alteration of the polarity
instructions that regulate the cytoskeletal components that
coordinate growth along the short and long axes.
2.3 Bactobolin
Bactobolin is a polyketide-peptide produced by a variety of
bacterial species including Pseudomonas and Burkholderia
thailandensis [16, 17]. It is a well-characterized antibiotic
and antitumor compound. It has been shown to induce
apoptosis in melanoma and lymphoma cells [18].
In S. pombe, bactobolin is the NP with the smallest L/Lc
ratio. This means that the mean length of cells treated with
bactobolin is less than those without NP. However, aspect
ratio does not change to a similar degree, within experi-
mental error. This NP therefore produces short cells that
retain normal length and width proportions. So when both
length and width are commensurately decreased, overall
growth has decreased. Since the beginning of apoptosis is
heralded by cell shrinkage in both upper and lower
eukaryotes [19, 20], it is possible that this small cell size
results from apoptosis. Clearly, more research is required
to address how bactobolin alters S. pombe morphology.
2.4 Tetrocarcin A
Tetrocarcin A is an antibiotic isolated from Micromonos-
pora chalcea, an actinomycete. It acts as an antibiotic
against gram-positive bacteria [21]. It has been found to
inhibit anti-apoptotic activity of Bcl-2, a membrane protein
responsible for generating anti-apoptosis signals in cells
[22].
In S. pombe, tetrocarcin A also shows a L/Lc less than
100 %, indicating that overall growth has decreased. It is
not clear how this NP leads to the production of small yeast
cells, since events downstream of Bcl-2 differ between
mammalian cells and S. pombe [23].
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2.5 Lonchocarpic Acid
Lonchocarpic acid is a 3-aryl-4-hydroxycoumarin. It origi-
nates from species of Derris sp. and Lonchocarpus sp.,
which are leguminous vines and climbing shrubs. Extracts of
these species have been used by Amazon tribes to catch fish,
and roots of both species were found to contain rotenone, a
well-known insecticide. The production of rotenone became
a major industry in the 1930s [24]. Lonchocarpic acid has
been used as a plant insecticide [25]. It is an antifeedant to
insect larvae and a natural coumarin [26].
Little appears in the scientific literature specifically
about lonchocarpic acid’s mechanism of action for either
its antifeedant or coumarin properties. As well, effects of
lonchocarpic acid on S. pombe have no presence in the
literature. However, the mechanism of action of rotenone,
which bears some structural similarity to lonchocarpic acid,
is that rotenone interferes with electron transport.
In S. pombe, lonchocarpic acid exhibits an AR/ARc
considerably higher than control, indicating that cells are
more rounded than control. Cell polarity instructions are
therefore compromised. This may be due to generation of
free radicals that affect the cytoskeleton, in a mode similar
to that of artemisinine. Although lonchocarpic acid may
not require heme to operate, its potential interference with
electron transport may imply the presence of radicals that
affect cell polarity in a similar manner.
2.6 Michellamine B
Michellamine is an alkaloid that originates from the trop-
ical liana plant Ancistrocladus korupensis. It is an antiviral
agent [27]. It inhibits cell killing by HIV in two pathways:
inhibition of both reverse transcriptases as well as pro-
cesses of cellular fusion. It is considered a leading anti-HIV
agent such that efficient routes for its synthesis are being
sought and achieved [28]. It has been found that michell-
amine B also inhibits protein kinase C in the rat brain [29].
Michellamine B yields an AR/ARc lower than 100 %, so
the cells are elongated. It seems to shorten the cells slightly
as well, although within experimental error: L/Lc is very
close to 100 %. This is consistent with the inhibition of
protein kinase C described above. S. pombe has a family of
protein kinase C homologues called Rho1p GTPases [30].
When these are inhibited, pombe cells are unsuccessful at
maintaining cell polarity and cell wall integrity [31].
2.7 Parthenolide
Parthenolide is a sesquiterpene lactone that originates from
the feverfew plant Tanacetum parthenium but is now com-
mercially available [32]. It is known to strongly inhibit
nuclear factor jB and have antitumor and anti-inflammatory
properties. Its use in cancer inhibition has been patented
[32]. It also inhibits DNA methyltransferase 1, which
induces global DNA hypomethylation. So parthenolide acts
as a DNA damaging agent.
In S. pombe, parthenolide shows a strong effect and
produces cells with AR/ARc less than 100 %. This means
that the aspect ratio is lower than the control, or the cell is
rounded. However, parthenolide does not show a change in
L/Lc, so length is not changing. This means that the cells
are truly more elongated in shape: the same length but less
wide. This behavior may be attributable to the DNA
damage inflicted by parthenolide.
2.8 Inactive Group
Five of the NCI natural products tested showed no effect on
L/Lc or AR/ARc. These five are beta-lapachone, castano-
spermine, curcumin, glaucarubine, and triptolide analog.
Each is briefly discussed below.
2.9 Beta Lapachone
Beta lapachone is an orthonaphthoquinone originating
from the South American lapacho tree Tabebuia avell-
anadae. It has also shown anti-inflammatory and antibac-
terial properties [33]. It has shown a variety of bioactive
properties that are believed to be due to the quinoid moiety.
It is also known to promote apoptotic cell death by sensi-
tizing tumor cells toward DNA damaging.
2.10 Castanospermine
Castanospermine is an N-linked glycan from the Australian
chestnut tree Castanospermum australe. It possesses
known antiviral properties, and it operates by inhibiting
glucosidases required to form the envelope proteins sur-
rounding virus particles [34]. These glucosidases are
inhibited by castanospermine and its derivatives, because
they operate on N-linked glycans on the viral envelope
[35]. This affects morphogenesis of the virus particles. In
contrast, this compound has relatively little effect on
morphogenesis of S. pombe. This may be because its cell
wall consists largely of mannoproteins, alpha-glucan, and
beta-glucan, not N-linked glycans [36].
2.11 Triptolide Analog
Triptolide is an epoxide, and the triptolide analog used in this
study is very similar to triptolide except that it has undergone
ring opening in several places. Triptolide is extracted from the
Chinese herb Tripterygium wilfordii Hook F, called the
thunder god vine. It has been used in traditional Chinese
medicine, and it is an immunosuppressive agent and an
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anticancer agent. It has been shown to initiate apoptosis
mediated by lysosomes in breast cancer cells [37]. This
apoptosis also displays a cell shrinkage behavior in these
breast cancer cells. Such effects are not observed in S. pombe
in this study. This may be because S. pombe does not possess
lysosomes in the sense that mammalian cells do. But S. pombe
does contain vacuoles that behave similarly and occupy a
similar role [38].
2.12 Glaucarubine
Glaucarubine is a terpenoid compound within the general
group of quassinoids. It originates from the paradise tree, or
Simarouba glauca. Glaucarubine is known to act against
amebiasis [39]. A closely related compound, glaucarubinone,
has been shown to have a variety of anticancer activities,
originating from its inhibition of protein synthesis [40]. It also
has anti-inflammatory, insecticidal and antilarval activities
[41]. Its anti-inflammatory activities are related to its ability to
stabilize lysosomes, which reduces the release of enzymes that
do tissue damage [42]. Again, this lysosomal effect would not
be present in S. pombe, but it could relate to vacuoles in S.
pombe. At the time of this writing, no results on trials of
glaucarubin on pombe are published in the scientific literature.
2.13 Curcumin
Curcumin, or diferuloylmethane, is a diketone. It is derived
from the root of the plant Curcuma longa and is found in the
spice called turmeric derived from that root. Turmeric has
been used as a spice, dye, and folk medical remedy for
centuries. It is known to have strong antioxidant properties
[43]. It is an inhibitor of the nuclear factor jB pathway [44].
None of these properties have a clear connection to cell
morphology changes and in S. pombe, none are observed.
3 Conclusions
Twelve natural products from the NCI Natural Products Set
II were tested against S. pombe. Seven were found to have
significant effects on either cell length or aspect ratio. More
research is required to identify the mechanism of action of
each NP and thereby help describe cellular pathways that
regulate morphology.
4 Experimental Section
4.1 General Experimental Procedures
Two-dimensional fission yeast cell images were collected
with a FlowCAM imaging flow cytometer (IFC) with
peristaltic pump value of 10, 209 microscopic objective,
and 26 particle parameters (Fluid Imaging Technologies,
Yarmouth, ME). Optical densities at 595 nm (OD595) were
recorded on a Genesys 10 uv Scanning UV-Vis Spectro-
photometer (Thermo Fisher Scientific, Waltham, MA) with
100 Plastibrand UV-microcuvettes (Sigma-Aldrich, St.
Louis, MO) and a blank of YE5S broth media made from
yeast extract (Becton-Dickinson Bacto), dextrose (anhy-
drous, BDH), adenine hemisulfate dehydrate, (MP Bio-
medicals, Solon, Ohio), L-histidine free base (MP
Biomedicals), L-leucine (MP Biomedicals), and uracil (MP
Biomedicals) [45]. Cell cultures were prepared with a
VWR Incubator (Sheldon Manufacturing, Cornelius, OR)
at 30.5 C and a 120 rpm rotational shake function for
liquid solutions. Centrifugation was performed on a VWR
Galaxy 16D Centrifuge (Sheldon Manufacturing, Corne-
lius, OR) at 5,000 rpm over 2 min durations.
4.2 Natural Products
Khellin (NSC#8519), beta-lapachone (NSC#26326), glauca-
rubine (NSC#14975), curcumin (NSC#32982), tetrocarcin A
(NSC#333856), lonchocarpic acid (NSC#307981), artemisi-
nin (NSC#369397), parthenolide (NSC#157035), michell-
amine B (NSC#661755), castanospermine (NSC#614552),
triptolide analog (NSC#337783), and bactobolin
(NSC#325014) were obtained from the NCI Open Chemical
Repository Collection Developmental Therapeutics Program
(NCI/DTP) Natural Products Set II. The NPs were prepared in
DMSO as a stock solution which was later added to triplicate
biochemical assay analytes to achieve a NP concentration of
10 lM for the study.
4.3 Schizosaccharomyces pombe Acquisition
S. pombe wild-type fission yeast with genotype leu1-32,
h- ura4-d18 was stored on YE5S agar slant media in a
4 C refrigerator until use. Reanimation of the yeast was
accomplished in YE5S media broth with 24 h incubation at
30.5 C and a 120 rpm rotational shake.
4.4 Triplicate Biochemical Assay
After initial incubation, OD595 was measured using liquid
YE5S media as a blank. Following starter culture, transfer
volumes and growth times for final samples were carefully
controlled in order to obtain OD595 values between 0.2 and
0.9, so that log-phase growth and sufficient cell populations
could emerge, but plateau-stage growth and the accompa-
nying senescence and exhaustion of media nutrients would
not take place. Cell populations were asynchronous. The
transfer volume (Vtransfer) was calculated using the OD595
obtained from the starter culture and the formula below







 Vfinal where N ¼ tincub
tgen
:
The transfer volume was then halved or cut into thirds as
needed. This Vtransfer was added into 5 mL of YE5S media
and incubated at 30 C and 120 rpm for a minimum of
12 h. Following this uniform growth period, OD595 was
measured again. If OD595 exceeded 0.3, the sample was
diluted with media in order to achieve an OD595 of 0.3, to
ensure that plateau growth and senescence did not occur
during the 6 h period of NP exposure. Each individual NP
was then added to a triplicate group of cultures to yield a
final NP concentration of 10 lM. Control samples did not
have any NP added but underwent the same OD595
measurement, dilution, and 3 h growth period,
constituting a full growth cycle in S. pombe. OD595 was
measured once more; all final OD595 values lay between
0.2 and 0.9. The samples were centrifuged at 5,000 rpm for
2 min, washed in phosphate buffered saline (PBS, 0.2 M
Phosphate, 1.5 M NaCl), aspirated, centrifuged again, and
resuspended in 70 % cold ethanol to preserve samples. The
samples were stored at 4 C until ready for flow cytometric
analysis.
4.5 Imaging Flow Cytometry
Samples in ethanol were resuspended in PBS for analysis
using the IFC. Samples underwent two cycles of the fol-
lowing: centrifugation at 5,000 rpm for 2 min, removal of
supernatant, dilution in PBS, aspiration, and vortexing to
break-up cell clumps. Final samples in PBS were allowed
to incubate for 30 min prior to flow cytometric analysis.
Eight to ten drops of the sample solution was placed into
the opening of the FlowCAM IFC and 50,000 images were
collected. A library, consisting of 75 good cell images
collected as a skeleton representative of short to long
lengths, was made for each set of images corresponding to
NP or control samples. FlowCAM software was then
instituted to sort by like particle values, resulting in a
refined set of predominantly acceptable images. Manual
image deletion that was uniform across three individuals
was performed until only single cell images remained, with
an acceptable final image count at or above 8,000.
4.6 Data Analysis
A table containing 26 parameters for each cell was
exported to Microsoft Excel. The two parameters of
interest in this work were length and aspect ratio; mean
values of these were calculated in Excel. Triplicate trials of
each experiment yielded average values and standard
deviations for both mean length and aspect ratio.
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